(Q44283672)

1 December 2017

title

Safety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsy (English)

1 reference

1 December 2017

Ramsay RE

1

1 reference

1 December 2017

Cantrell D

2

1 reference

1 December 2017

Collins SD

3

1 reference

1 December 2017

Walch JK

4

1 reference

1 December 2017

Naritoku DK

5

1 reference

1 December 2017

Cloyd JC

6

1 reference

1 December 2017

Sommerville K

7

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

52

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

189-201

1 reference

Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Effect of infusion duration on valproate pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Intravenous loading of valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Intravenous valproate is well tolerated in unstable patients with status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Only certain antiepileptic drugs prevent seizures induced by pilocarpine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Valproic acid treatment of experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

Efficacy and safety of add-on divalproex sodium in the treatment of complex partial seizures. The M88-194 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900187-0

7 January 2021

10.1016/S0920-1211(02)00187-0

Identifiers

DOI

1 reference

1 December 2017

1 reference